Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 10;22:69. doi: 10.1186/s12935-022-02493-2

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

PMC Copyright notice

Fig. 4 — The association between immune-related lncRNA pair (IRLP) signature and clinical features. A The 18-IRLP signature can be considered an independent prognostic factor for gastric cancer (GC) based on the results of the multivariate Cox regression analysis. B The 5-year time-dependent receiver operating characteristic (ROC) curves of the 18-IRLPs signature, traditional TNM staging, and other clinical features. C The distribution of the risk score and survival status in the patients. D The results of molecular subtype clustering using the consensus clustering method. E The Kaplan–Meier (K-M) plot of the three subtype clusters (log-rank test, P-value < 0.001)